Promising research data surrounding Retatrutide , specifically the 120mg formulation referred to as ZPHC, suggest a significant impact on body mass reduction and related health illnesses . Researchers posit that this innovative acting , affecting both GLP-1 and GIP receptors , may represent a major advance in the treatment of overweight and connec